Ashish Dhir
Senior Manager, Pharmacology & Toxicology @Memorial Sloan Kettering Cancer Center
Signup · Get unlimited contacts
WORK HISTORY
Senior Manager, Pharmacology & Toxicology @Memorial Sloan Kettering Cancer Center
NY, US
Part of the Product Development team within Office of Technology Development (OTD) of MSK. Responsible for designing IND-enabling studies of anticancer molecules (small molecules and biologicals), writing of IND sections (Pharmacology & Toxicology), submission of IND to FDA (eCTD).
EDUCATION
Panjab University
Masters in Pharmacology, Pharmacology
Panjab University
PhD, Pharmacology
Panjab University
Bachelor's degree, Pharmacy, 1st
ABOUT ASHISH DHIR
A scientist with more than 15 years of research experience in preclinical pharmacology. Skilled in key areas of neuropharmacology/neurology preclinical research with a record of accomplishment in drug discovery gained from both industry and academia. Two-time recipient of Young Investigator Award by International School of Neuropsychopharmacology in meetings held at Munich (Germany) and Vancouver (Canada). Recently included in the list of the world \'s top 2% pharmacology scientists (Ranking 1053 out of 94611) based on Scopus Citations and composite score, published in Plos Biology, 2020. Excellent interpersonal skills and effective team member. Professional experience working with industries, CROs, and collaborators. Worked as an Associate Principal Scientist (Biology-Drug Discovery) at Merck Animal Health- MRL Liaison Group. Currently working in the Office of Technology Development at Memorial Sloan Kettering Cancer Center (NY) looking after IND enabling studies of anti-cancer molecules. Specialties: Preclinical pharmacology, Early Drug discovery (human and veterinary products), Business Development, epilepsy, neurosteroid, benzodiazepines, TARP-gamma8 AMPA receptors, cannabidiol (CBD) and epilepsy models, neuropsychiatric and cognitive disorders, inflammation research, EEG analysis, behavioral pharmacology, in-vivo preclinical models, refractory epilepsy models, spontaneous recurrent seizures, chemical kindling.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.